HC Wainwright Reaffirms Buy Rating for Cadrenal Therapeutics (NASDAQ:CVKD)
HC Wainwright restated their buy rating on shares of Cadrenal Therapeutics (NASDAQ:CVKD – Free Report) in a research note issued to investors on Friday,Benzinga reports. They currently have a $32.00 price objective on the stock. Cadrenal Therapeutics Price Performance Shares of Cadrenal Therapeutics stock opened at $15.50 on Friday. The company has a market cap […]
HC Wainwright restated their buy rating on shares of Cadrenal Therapeutics (NASDAQ:CVKD – Free Report) in a research note issued to investors on Friday,Benzinga reports. They currently have a $32.00 price objective on the stock. Cadrenal Therapeutics Price Performance Shares of Cadrenal Therapeutics stock opened at $15.50 on Friday. The company has a market cap […]
